Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Life Sciences





The drugmaker is reportedly accused of excessive pricing for anti-TB drug bedaquiline and patent evergreening
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
A WIPO committee meets this week to debate a draft text that would require patent filers to disclose their use of genetic resources and associated traditional knowledge
The UPC will decide whether to grant 10x Genomics a preliminary injunction against Nanostring on September 19
The Taiwanese biotech firm is the first commercial entity to share IP and know-how via a WHO pool set up in 2020
A statement from health ministers arrived as negotiations over pandemic prevention measures continue at the WHO
Samsung Bioepis’s biosimilar of a drug used to treat a rare blood disorder will remain on the German market
The Munich Regional Court has already granted a preliminary injunction restricting the sale of Amgen’s biosimilar version of orphan drug Soliris
Alexion obtained a preliminary injunction in Munich barring Amgen from selling a biosimilar version of its antibody drug
The Delhi High Court said third parties who use different processes to make a patented product can’t be restricted if the plaintiff’s registration covers a product-by-process patent
J&J has granted licences to the Stop TB Partnership after months of campaigner pressure over its patent strategy
The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor
Sponsored

Sponsored

A recent decision makes obviousness-type double patenting a real concern for applicants but some sources think a Supreme Court review is on the cards
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Samantak Ghosh, senior IP counsel at Gilead, talks about his pivot from research to law, the rise of biologics, and his pro bono work
The ‘M’ in the company’s ‘COVID MVAX’ applied-for trademark could help it prevail against claims of genericism, though the outcome is still uncertain, say counsel
Interviews; Exclusives

Interviews; Exclusives

Each week Managing IP speaks to a different IP lawyer about their life and career
Each week Managing IP speaks to a different IP lawyer about their life and career
Counsel at Sanofi reveal how they anticipated what questions US Supreme Court justices would throw at them and other challenges in the long-running case against Amgen
Alex Liu discusses the opportunities and challenges for pharma innovators in China and how he led his team to a record patent win
Law firm Susman Godfrey’s John Lahad explains how his firm and its co-counsel snagged a $42 million verdict for the University of Texas System and TissueGen
Dagg tells Managing IP about being starstruck when dealing with Nobel Prize-winning inventors, and how she deals with self-doubt
In the latest episode of our monthly podcast, the team discusses law firm merger strategies, a high-profile break-up, and the latest 5G patent developments
In the latest episode of our monthly podcast, the team discusses their early memories of covering IP before delving into the latest on the UPC and whether a proposed US study could threaten the future of pharma patents
In the latest episode of our monthly podcast, the team discusses US and Asian approaches to the UPC, updates to trademark law in Japan and China, and the latest attempt at US patent reform
In the latest episode of our monthly podcast, the team joins you live from the Managing IP Intellectual Property & Innovation Summit in London, where SEPs and the UPC were both top of mind
In the third episode of our monthly podcast, the Managing IP editorial team unpacks SEP news, the probe into Judge Pauline Newman, and the biggest stories elsewhere
In the second episode of our monthly podcast, the Managing IP editorial team unpacks a busy month at SCOTUS, the EU’s solution to the FRAND conundrum, and the biggest stories elsewhere
In the first of a new monthly podcast, the Managing IP editorial team unpacks the race for the top job at the EUIPO, the key UPC trends to watch, and the biggest stories in Asian IP
Phyllis Turner-Brim talks about her career, the need for balance in intellectual property policy and her passion for diversity and inclusion
Derek Gilliland, who became a magistrate judge at the Western District of Texas this month, delves into his work, thoughts on Alan Albright and ambitions
Kirupa Pushparaj talks about his move to a fintech start-up focused on young-person financial independence, career progression and start-up IP needs
ad ros bottom lb